Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, Catovsky D; UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. Dearden C, et al. Among authors: milligan d. Blood. 2008 Feb 15;111(4):1820-6. doi: 10.1182/blood-2007-07-101303. Epub 2007 Nov 30. Blood. 2008. PMID: 18055869 Free article. Clinical Trial.
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. Starczynski J, et al. Among authors: milligan d. Br J Haematol. 2003 Oct;123(1):66-71. doi: 10.1046/j.1365-2141.2003.04563.x. Br J Haematol. 2003. PMID: 14510944 Free article.
Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, Matutes E, Milligan D; Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology. Oscier D, et al. Among authors: milligan d. Br J Haematol. 2004 May;125(3):294-317. doi: 10.1111/j.1365-2141.2004.04898.x. Br J Haematol. 2004. PMID: 15086411 Free article. Review. No abstract available.
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
Delgado J, Pratt G, Phillips N, Briones J, Fegan C, Nomdedeu J, Pepper C, Aventin A, Ayats R, Brunet S, Martino R, Valcarcel D, Milligan D, Sierra J. Delgado J, et al. Among authors: milligan d. Br J Haematol. 2009 Jun;145(6):801-5. doi: 10.1111/j.1365-2141.2009.07699.x. Epub 2009 Apr 15. Br J Haematol. 2009. PMID: 19388937 Free article.
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses.
Milligan DW, Fernandes S, Dasgupta R, Davies FE, Matutes E, Fegan CD, McConkey C, Child JA, Cunningham D, Morgan GJ, Catovsky D; National Cancer Research Institute Haematological Studies Group. Milligan DW, et al. Blood. 2005 Jan 1;105(1):397-404. doi: 10.1182/blood-2004-01-0298. Epub 2004 Apr 29. Blood. 2005. PMID: 15117764 Free article. Clinical Trial.
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group. Burnett AK, et al. Among authors: milligan d. Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8. Br J Haematol. 2009. PMID: 19291085 Free article. Clinical Trial.
386 results